• P-ISSN 2394-9481 E-ISSN 2394-949X
  • Before December 2023, article status/review can be accessed using old submissions tab

Journal of Medical Sciences and Health

Journal of Medical Sciences and Health

Year: 2023, Volume: 9, Issue: 1, Pages: 110-117

Review Article

Report of an Unusual Case of Hemosiderotic Fibrohistiocytic Lipomatous Tumor with Systematic Review of Clinicopathological Characteristics and Differential Diagnosis

Received Date:19 September 2022, Accepted Date:12 April 2023, Published Date:15 May 2023

Abstract

 

The spectrum of lipomatous lesions ranges from benign to highly malignant disease. Differentiation between these mesenchymal lesions is important for pathologist as well as clinician to indicate prognosis and choose the most appropriate treatment. Hemosiderotic firohistiocytic lipomatous tumor (HFLT) is a rare subtype of lipomatous tumor. The diagnosis is usually based on clinical, histological, and immunohistochemical (IHC) information. We reported a case of 56 years old man with a painful mass in the dorsal aspect of the thigh showing an unusal clinical presentation but a characteristic histological and IHC features. In this article we have retrospectively reviewed the 67 cases of HFLT reported in literature so far along with one case reported at our institution. The review focuses on clinicopathological and histomorphological characteristics of HFLT and the related entities. The hallmark of HFLT and its related lesions is complex admixture of mature adipose tissue, spindle tumor cells with striking deposition of hemosiderin pigment. Even though HFLT shows marked predeliction for the distal extremeties especially the foot/ ankle with a female preponderance, they can occur at uncommon site such as thigh and also in males as seen in our case.

Keywords: Pleomorphic hyalinizing angiectatic tumor, Hemosiderotic fibrolipomatous tumor, Myxoinflammatory Fibroblastic Sarcoma, Hemosiderin, Lipoma

Introduction

Hemosiderotic Fibrohistiocytic Lipomatous Tumor (HFLT), Pleomorphic Hyalinizing Angiectatic Tumor (PHAT), and Myxoinflammatory Fibroblastic Sarcoma (MIFS) are rare mesenchymal neoplasms with a tendency for the distal lower extremities. Although each of these entities have been described independently in literature, various histological and genetic observations over the past two decades have led to speculation that these tumors may be interrelated. This hypothesis is based on both histomorphological and genetic features, but the exact relationship between these three entities remains a topic of controversy and debate for the scholars. In this article, we have analyzed the key histomorphologic and immunohistochemical (IHC) features of a case of HFLT which showed an unusual clinical presentation and a discussion about the closest differentials which easily confuses the pathologist and lead to chances of misdiagnosis. Since the available literature over these entities are limited, we hereby will evaluate the relationship between these tumors.

The spectrum of lipomatous lesions ranges from

Case presentation

A 63-year-old male presented to surgery department of our institution with a painless swelling over upper one third of right thigh. The patient had noticed the lesion one and a half year before, which has gradually progressed to the present size (24×12 cm). There was no significant medical history or history of trauma. Family history was noncontributory. On physical examination, swelling was 24x12 cm with ill-defined margins, which was non tender, with no local rise of temperature. On further examination, patient had difficulty in flexion and external rotation of thigh and a resistance involving half the anterior medial side of the thigh was present. MR imaging revealed lipomatous lesion of the right thigh measuring 28× 13 × 10 cm with irregular boundaries. The lesion showed multiple far-reaching intramuscular and subfascial extensions. The assessment of internal structures showed a homogeneous, lobulated lesion suspicious of liposarcoma.

Complete tumor resection was performed with free margins. After resection the specimen was subjected to histopathological evaluation.

The specimen was fixed in 10% neutral formalin, then conventional paraffin sectioning and hematoxylin and eosin (H&E) staining were performed. The morphology of tumor tissue was observed under a light microscope.

On gross examination, lipomatous lesion measured 28×13×10cm. It was darker yellow than the normal surrounding fat. External surface was well circumscribed, congested and showed blood vessels. Cut surface showed collated appearance. Cystic areas were filled with necrotic debris and hemorrhagic areas were made out (Figure 1).

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/338eef07-7ae0-4218-982d-5e9eeae934e3image1.png
Figure 1: Cut section of the tumor showing solid and cystic areas. Areas of necrosis noted

Microscopically, ten representative samples throughout the whole tumor were reviewed. Histopathological examination revealed a neoplastic lesion composed of spindle cells infiltrating into adipocytic component in a honey comb pattern . These spindle cells had elongated, vesicular nuclei, inconspicuous nucleoli and scanty cytoplasm. The adipocytic component was mature without atypia and no lipoblasts were seen. There were numerous small to large ectatic blood vessels with a number of them showing organising thrombi, aggregates of histiocytes containing hemosiderin pigment (Figure 2). No evidence of increased mitotic activity was noted. On IHC staining of CD34, a notable diffuse staining primarily of the spindle cells, fibrocytes and vascular endothelium was seen (Figure 3). On staining with CD68 we found out positive staining for macrophage lineage such as tissue histiocytes. (Figure 4)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/338eef07-7ae0-4218-982d-5e9eeae934e3image2.png
Figure 2: Photomicrograph showing varying proportions of bland spindle cells, mature adipose tissue, ectatic blood vessels and hemosiderin pigment. The spindle cells are seen in the fascicular and whorled arrangement dissecting the adipocyte component in honey comb pattern (H&E, 10x)
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/338eef07-7ae0-4218-982d-5e9eeae934e3image3.png
Figure 3: Photomicrograph showing CD34 immunostaining showing diffuse positivity of capillary endothelium and spindle cell component (40x)
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/338eef07-7ae0-4218-982d-5e9eeae934e3image4.png
Figure 4: Photomicrograph showing CD68immunostaining showing diffuse positivity for macrophages (40x)

By combining histology and IHC features of resected specimen with clinical information, the diagnosis of HFLT was established. There were no operative or post-operative complications noted. Eighteen months after the excision, the patient continued to show no signs of recurrence.

Methods

We reviewed 67 cases of HFLT from the literature, published in English and Portuguese language which were available at Pubmed data base (Table 1).

Case reports, articles that diagnosed HFLT with adequate evidence supported by gross examination, histology, biopsy and previous recurrrences were included. Demographic data such as age at diagnosis, gender, location and size were recorded. An attempt to look for clinico-pathologic features of HFLT along with IHC features was done. All the 67 cases were studied using descriptive statistics.

Table 1: Data collection

Data base

Results

Pubmed

8 Original articles

3 Letter to editor

1 Updating article

3 Case series

7 Case reports

4 Review articles

1 Research article

1 Short communication 1 Scientific article

Results

The demographic characteristics of all HFLT included were studied and tabulated (Table 2). Our review of the literature suggests that HFLT predominately presents in middle-aged women (median age being 50 years and mean age being 51 years). Age group ranged from 7 months to 78 years, the ratio of male to female was 1: 2.6 with close to half (46%) the cases having a history of trauma or vascular disease.

HFLT occurs within the soft tissue of limb extremities, with foot/ankle accounts for 77%, but also involves the hands,123 forearm,45 wrist6 and one case involving cheek and finger. 7

It has been reported that majority cases of HFLT are characterized by CD34 expression in spindle cells and vascular endothelium.

It was noted that HFLT needs to be pathologically distinguished from related adipocytic lesions such as PHAT and MIFS which share similar location and morphologic characteristics. Summary of key morphological and genetic features of adipocytic lesions are tabulated in Table 3.

Table 2: Demographicand morphological characteristics of cases from reviewed studies

Study

Year

Number of patients

Gender

Average age in years

Localisation

Size

Marshall et al. 7

2000

10

2 - Male 8- Female

50.6

8 - Foot 1 - Cheek, 1- Finger

Range 2.5 -17cm

Kazakov et al. 8

2005

2

2 - Female

54

1- Foot 1- Foot

6x5x4 cm

Browne et al. 1

2005

13

6 - Male 7 - Female

49

12- Ankle/foot 1 - Hand

Range 1- 13cm

Luzar et al. 9

2006

1

Female

47

Ankle

1.9x1.2 cm

West et al. 10

2007

1

Female

38

Foot

NA

de Vreeze et al. 11

2008

1

Male

66

Thigh

19x8x4 cm

Wettach et al. 12

2008

1

Female

35

Foot

NA

Hallor et al. 13

2008

1

Female

40

Ankle

NA

Ramalho et al. 14

2009

1

Female

33

Knee

10x8x6 cm

Moretti et al. 15

2010

1

Female

56

Foot

7x5x2 cm

Antonescu et al2

2011

14

2 - Male 12 - Female

45

13 - Foot 1 - Hand

NA

Sawalha Setal. 3

2011

1

Female

55

Hand

3x1 cm

Carter et al. 4

2014

7

3 - Male 4 - Female

53

4 - Foot 3 - Forearm

NA

O’Driscoll et al. 5

2014

5

3 - Male 2 - Female

60

4 - Foot 1 - Forearm

18 cm

Marusic Z et al. 16

2014

1

Female

57

Ankle

15x5 cm

Zreik et al. 17

2016

1

Female

77

Foot

NA

Morency et al18

2016

1

Female

55

Foot

3x1 cm

Wilk et al. 19

2016

1

Female

45

Foot

14x6 cm

Etchebehere et al. 20

2016

1

Female

38

Thigh

22x18x11cm

Hou et al. 21

2018

1

Male

50

Knee joint

4x2.5x1.9cm

Bourhroum N et al. 22

2019

1

Female

50

Ankle

7 cm

Pang CY et al. 6

2021

1

Female

45

Wrist

NA

Current study

2022

1

Male

63

Thigh

28x13x10cm

NA - Not available

Discussion

HFLT is a rare benign fibrolipomatous lesion first described as an entity in 2000 by Marshall - Taylor and Fanburg - Smith. It accounts for 0.2% of benign lipomatous lesion. 7

HFLT generally affects the ankle and the dorsum of the foot, although it may appear in other locations such as cheeks and hands. It typically affects adults, more commonly females, in the 5th and 6th decades of life. The distinct feature about our case is its huge size, site and occurrence in male. Thigh is not the usual site of presentation. Our case and only two other cases in literature (de Vreeze et al. 11 and Etchebehere et al.20) have reportedthigh as the location.

Histologically, it is characterized by a lipomatous lesion composed of three elements occurring in varying proportions. These elements include mature adipocytes, spindle cells and hemosiderin pigment, which is present predominantly in macrophages within the spindle cell areas, whose original deposit is unclear. The mature adipose tissue is infiltrated by strands of fibrous tissue featuring fibroblastic spindle cells and hemosiderin deposits.

Scattered areas with atypical pleomorphic cells may be present. Focal clusters of ectatic blood vessels as seen in PHAT are not uncommon. Chronic inflammatory cells are usually seen in the background. Mitosis or necrosis are usually not seen. CD34 positivity clearly differentiates the fibroblastic differentiation while CD68 positivity shows diffuse staining for the macrophages. 1

Adipocytic lesions with overlapping clinical and histopathological features

There is an ongoing debate about the resemblance of early PHAT and HFLT; some consider HFLT a precursor lesion of PHAT, implicating HFLT to be a neoplastic lesion, 823others consider HFLT an individual more reactive lesion. 19

HFLT and PHAT

The hypothesis that PHATis related to HFLT was first suggested by Folpe and Weiss 24 in their 2004 study on 41 PHAT cases. These investigators noted that in nearly 50% of their cases, there was the presence of areas which were morphologically indistinguishable from HFLT at the periphery.

These HFLT-like areas were labeled “early PHAT,” and were felt to represent the precursor lesion to classic PHAT 24.PHAT and HFLT both shares recurrent t(1;10) (p22;q24) rearrangement involving the TGFBR3 and MGEA5 genes. 132

Same as HFLT, PHAT also has usually middle-aged adults preponderance and a proclivity for the lower extremities, though a few cases has occurred at the sites such as the arm, thigh, buttocks, or trunk with a median size of approximately 6cm. Becauseangiectatic vessels is a prominent feature, PHAT quite a few times is clinically mistaken for a hematoma or vascular neoplasm. PHAT is a vaguely circumscribed mass composed of spindled or pleomorphic cells surrounding clusters of thin-walled, ectatic vessels with sub-endothelial and intraluminal fibrin deposits and perivascular hyalinization.

Although PHAT could appear circumscribed at low power, the margin is typically infiltrative. The lesional cells range from spindled to strikingly pleomorphic and shows frequent intranuclear inclusions. Mitotic activity in PHAT is very low (<1/50 HPF). Hemosiderin deposits can be seen in macrophages or in the cytoplasm of the lesional cells. Scattered inflammatory cells are usually present. 25

Myxoid stroma is focally present and usually there is a prominent inflammatory component. Cytologically, HFLT is consists of bland fibroblasts without significant mitotic activity and may contain scattered osteoclast-type giant cells. Small ectatic vessels with mural hyalinization or fibrinous thrombi may be present. 124 HFLT-like areas can be found at the periphery or admixed with otherwise typical examples of PHAT. This observation led to a hypothesis that HFLT may well be a precursor lesion to PHAT. 24

In few rare cases it is seen that, PHAT and HFLT has progressed to a sarcoma of variable histologic grade, more often with in the setting of recurrences.132417 The sarcomas in such cases have myxoid stroma and a prominent inflammatory infiltrate and shows morphologic resemblance to MIFS. Solid, undifferentiated spindle cell sarcoma-like morphology has also been reported. 17

Most PHATs and HFLTs are both positive for CD34 and negative for S100, SMA, and desmin. 742324

HFLT and MIFS

MIFS also referred as “inflammatory myxohyaline tumor of the distal extremities,” 26 “acralMIFS,”27 and “inflammatory myxoid tumor of the soft parts with bizarre giant cells,”28 is a locally aggressive, rarely metastasizing, fibroblastic tumor of borderline malignancy that typically involves the distal extremities of middle-aged adults.

The marginal region of a PHAT, and MIFS demonstrates overlapping histomorphogy with HFLT. There is seen relatively mild spindle-cell infiltration of adipose tissue and deposition of hemosiderin. However, PHAT shows obvious plexiform expansion of thin-walled vessels with fibrin-like material deposition, and cytoplasmic pseudo inclusion bodies seen with in the nuclei of tumor cells. MIFS lesions contain high mucus-but low adipose-content, while usually little or no mucus is produced in HFLT

Literature suggests that there does not seem to be a direct morphologic link between HFLT and MIFS, and the available molecular genetic data within the literature are contradictory, likely attributable to the use of different morphologic criteria for the diagnosis of MIFS by different investigators. Although cases are described as representing “hybrid HFLT-PHAT,” the preponderance of evidence suggests that such lesions are way more closely associated with HFLT and PHAT representing a sort of morphologic progression to high grade myxoid sarcoma.

Conclusion

Ambiguity existed about reactive or neoplastic origin of HFLT. It is now well-established on the basis of histomorphology and molecular genetic evidence that HFLT and PHAT represent different manifestations of a single entity, with HFLT representing the precursor or “early” lesion of classic PHAT. The hallmark of these lesions is complex admixture of mature adipose tissue, spindle tumor cells with striking deposition of hemosiderin pigment. Even though HFLT shows marked prediliction for the distal extremeties especially the foot/ ankle and female gender, they can occur at uncommon site such as thigh and in a male patient as seen in our case.

Table 3: Summary of key morphologic and genetic features of adipocytic lesions

Diagnosis

Morphologic Features

Association with HFLT

Molecular alteration

HFLT

Mature adipose tissue, myxoid stroma CD34-positive spindled cells with intracytoplasmic hemosiderin deposition CD68 -positive macrophagesseen Small aggregates of variable sized blood vessels Areas resembling “miniature” PHATs

Not applicable

Frequent

PHAT

Clusters of thin-walled, ectatic blood vessels, containing organizing thrombi and surrounded by amorphous eosinophilic material Pleomorphism seen, CD34-positive tumor cells with intranuclear pseudoinclusions and intracytoplasmic hemosiderin deposition Low-mitotic activity Chronic inflammatory cell infiltrate Peripheral areas identical to HFLT

Yes

Frequent

MIFS

Multinodular and poorly circumscribed hyalinized zones, typically containing bizarreappearing cells with prominent macronucleoli Areas of dense chronic inflammation myxoid nodules, often containing multivacuolated (“lipoblast-like”) fibroblastic cells Mitotic activity is low Necrosis not seen Arborizing, thick-walled vessels as seen in myxofifibrosarcoma is usually absent here CD34 positive

No

Infrequent

HFLT with progression to myxoid srcoma (“hybrid HFLT-MIFS)

Areas of typical HFLT Myxoid sarcoma showing a well-developed, thick-walled vasculature Pseudolipoblasts may be seen Absence of hyalinized zones Absence of “Reed-Sternberg-like” or “virocytelike” cells

Yes

Frequent

Adapted from: Boland & Folpe 25

Abbreviations

HFLT: Hemosiderotic Fibrohistiocytic Lipomatous Tumor; PHAT: Pleomorphic Hyalinizing Angiectatic Tumor, MIFS: Myxoinflammatory Fibroblastic Sarcoma; TGFBR3: Transforming Growth Factor Beta Receptor 3; MGEA5: Meningioma Expressed Antigen 5; IHC: Immunohistochemical

 

Conflict of interest

Nil

References

References

  1. Antonescu CR, Zhang L, Nielsen GP, Rosenberg AE, Cin PD, Fletcher CDM. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumorGenes Chromosomes and Cancer2011;50(10):757764. Available from: https://doi.org/10.1002/gcc.20897
  2. Sawalha S, Low A, Packer N. Recurrent haemosiderotic fibrohistiocytic lipomatous lesion of the handMalaysian Journal of Pathology2011;33(1):4345. Available from: https://pubmed.ncbi.nlm.nih.gov/21874751/
  3. Carter JM, Sukov WR, Montgomery E, Goldblum JR, Billings SD, Fritchie KJ, et al. TGFBR3 and MGEA5 Rearrangements in Pleomorphic Hyalinizing Angiectatic Tumors and the Spectrum of Related NeoplasmsAmerican Journal of Surgical Pathology2014;38(9):11821992. Available from: https://doi.org/10.1097/pas.0000000000000212
  4. Pang CY, Wong E, Liao JW, Chan J, Cheuk W, Fibrolipomatous. Pauci-Hemosiderotic” Fibrolipomatous Tumor: A Mimicker of Various Lipomatous LesionsInternational journal of surgical pathology2021;29(1):6468. Available from: https://doi.org/10.1177/1066896920930799
  5. Moretti VM, Brooks JSJ, Ogilvie CM. Case Report: Hemosiderotic Fibrohistiocytic Lipomatous LesionClinical Orthopaedics & Related Research2010;468(10):28082813. Available from: https://doi.org/10.1007%2Fs11999-010-1242-7
  6. Marusic Z, Cengic T, Dzombeta T, Vucicm. Hybrid myxoinflammatory fibroblastic sarcoma/hemosideroticfibrolipomatoustumor of the ankle following repeated traumaPathol Int2014;64(4):195197. Available from: https://doi.org/10.1111/pin.12153
  7. Wilk M, Zelger BG, Zelger B. Hemosiderotic Fibrolipomatous TumorThe American Journal of Dermatopathology2016;38(9):714716. Available from: https://doi.org/10.1097/DAD.0000000000000540
  8. Etchebehererm RM, Almeida ECS, Santos CDT, Micheletti AMR, Leitão AS. Sarcomatous transformation of a hemosideroticfibrohistiocytic lipomatous tumor: a case reportRev Bras2016;52(3):366369. Available from: https://doi.org/10.1016/j.rboe.2016.11.002
  9. Hou W, Li C, Guo C, Zhang L, Meng X, Liu Q. Primary hemosideroticfibrolipomatous tumor in bone: a case report and review of the literatureInt J Clin Exp Pathol2018;11(5):24972505.
  10. Kazakov DV, Sima R, Michal M. Hemosiderotic fibrohistiocytic lipomatous lesion: clinical correlation with venous stasisVirchows Archiv2005;447(1):103106. Available from: https://doi.org/10.1007/s00428-005-1223-5
  11. Luzar B, Gasljevic G, Juricic V, Bracko M. Hemosiderotic fibrohistiocytic lipomatous lesion: Early pleomorphic hyalinizing angiectatic tumor? Pathology International2006;56(5):283286. Available from: https://doi.org/10.1111/j.1440-1827.2006.01955.x
  12. West AT, Toms AP, Murphy J, Sultan M. 2008;37(1):7174. Available from: https://doi.org/10.1007/s00256-007-0397-0
  13. Vreeze RSAD, Koops W, Haas RL, Coevorden FV. An Unusual Case of Hemosiderotic Fibrohistiocytic Lipomatous Lesion: Correlation of MRI and Pathologic FindingsSarcoma2008;2008:14. Available from: https://doi.org/10.1155%2F2008%2F893918
  14. Wettach GR, Boyd LJ, Lawce HJ, Magenis RE, Mansoor A. Cytogenetic analysis of a hemosiderotic fibrolipomatous tumorCancer Genetics and Cytogenetics2008;182(2):140143. Available from: https://doi.org/10.1016/j.cancergencyto.2008.01.012
  15. Hallor KH, Sciot R, Staaf J, Heidenblad M, Rydholm A, Bauer HC, et al. Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesionsThe Journal of Pathology2009;217(5):716727. Available from: https://doi.org/10.1002/path.2513
  16. Ramalho ARO, Nunes MN, Adad SJ, Leitão SA, Micheletti AMR. Hemosiderotic fibrohistiocytic lipomatous lesion: case report and review of the literatureSao Paulo Medical Journal2009;127(3):174176. Available from: https://doi.org/10.1590/s1516-31802009000300012
  17. Meis-Kindblom JM, Kindblom LG. Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feetAm Journal of Surgical Pathology1998;22(8):911924. Available from: https://doi.org/10.1097/00000478-199808000-00001
  18. Michal M. Inflammatory Myxoid Tumor of the Soft Parts with Bizarre Giant CellsPathology - Research and Practice1998;194(8):529533. Available from: https://doi.org/10.1016/s0344-0338(98)80041-1

DON'T MISS OUT!

Subscribe now for latest articles and news.